Singapore
+918265041513
+918265041513

Rompag 50mg (Generic Revolade) London — Eltrombopag for Chronic ITP & Aplastic Anaemia

For patients with chronic Immune Thrombocytopenia (ITP) and severe aplastic anaemia who have not responded to standard treatments, Eltrombopag 50mg — available as Rompag from Unnati Pharmax — is a critical second-line treatment recommended by NICE and the British Society for Haematology. London's specialist haematology units at King's College Hospital, St Bartholomew's, and University College Hospital frequently prescribe higher-dose Eltrombopag for these complex cases.

Rompag 50mg provides double the dose of the 25mg formulation, used when lower doses do not achieve the target platelet count. For aplastic anaemia — a serious bone marrow failure condition — Eltrombopag 50mg is used at doses up to 150mg daily as part of combination immunosuppressive therapy, often producing remarkable platelet and haematopoietic responses in patients who previously had few options.

London's private haematology sector sees significant demand for Eltrombopag from international patients and self-funding UK residents who face long NHS waiting times or require supply between NHS prescriptions. Indian generic Rompag 50mg provides substantial cost savings versus brand Revolade, without compromising on quality or efficacy.

Unnati Pharmax supplies Rompag 50mg to haematology pharmacies, specialist clinics, and patients across London and the UK. Visit medshopy.com or WhatsApp +91 82650 41513 for orders and wholesale pricing.
 2026-06-13T11:43:44

Other Pages

View all pages